Pharmacological effect of histone deacetylase inhibitors on pulmonary arterial hypertension
Pulmonary hypertension (PH) is characterized by structural remodelling of pulmonary arteries and arterioles, the result, at least in part, of excessive cell proliferation, resistance to cell death and hyperactive inflammatory reactions. Currently available treatments targeting the hyper-proliferativ...
Main Author: | Chen, Chien-Nien |
---|---|
Other Authors: | Zhao, Lan ; Wilkins, Martin ; Hajji, Nabil |
Published: |
Imperial College London
2012
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.624053 |
Similar Items
-
Investigating the neuroprotective effects of histone deacetylase inhibitors in Parkinson's disease
by: Harrison, Ian
Published: (2014) -
Molecular Characterization of Histone Deacetylase Inhibitor-mediated Immunosuppression and Thrombocytopenia
by: Matsuoka, Hideaki
Published: (2010) -
Investigation of the use of histone deacetylase inhibitors for the treatment of inherited disorders of the glycolytic pathway
by: Makarona, Kalliopi
Published: (2013) -
The preclinical and clinical pharmacology of novel histone deacetylase inhibitors
by: Kristeleit, Rebecca Sophie
Published: (2008) -
Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
by: Monica Phimmachanh, et al.
Published: (2020-10-01)